Polymorphic and amorphous salt forms of squalamine dilactate

Details for Australian Patent Application No. 2006239811 (hide)

Owner Genaera Corporation

Inventors Doubleday, Mary; Armbruster, Kyle; Levitt, Roy C.; Gilbert, Charles; Zhang, Xuehai; Chellquist, Eric; Mclane, Michael

Agent Allens Arthur Robinson

Pub. Number AU-B-2006239811

PCT Pub. Number WO2006/116309

Priority 60/674,531 25.04.05 US

Filing date 25 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 2 February 2012

International Classifications

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116309 Priority application(s): WO2006/116309

24 March 2011 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor to read Armbruster, Kyle 2007

2 February 2012 Application Accepted

  Published as AU-B-2006239811

3 May 2012 Assignment before Grant

  Genaera Corporation The application has been assigned to Ohr Pharmaceutical, Inc.

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239813-Opioid receptor agonist compounds and their use in treatment of pain

2006239809-Bone fixation apparatus